563
Participants
Start Date
March 1, 2020
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
Valganciclovir Oral Solution [Valcyte]
Treatment for CMV
Tuberculostatic Agents
Treatment for tuberculosis
Fundación para la Investigación Biomédica del Hospital 12 de Octubre, Madrid
Programme PACCI. Centre Hospitalier Cocody., Abidjan
Université de Bourdeaux, Bourdeaux
INSERM, Toulouse
PENTA Foundation, Padua
Malawi Liverpool Welcome Trust. Queen Elizabeth Central Hospital College of Medicine, Blantyre
Cemtro de Investigaçao em Saúde da Manhiça, Manhiça
Hospital Central Maputo, Maputo
Stichting Katholieke Universiteit Radboudumc, Nijmegen
Makerere University - Mulago Hospital, Kampala
University of Lincoln, Lincoln
Lusaka Teaching Hospital, Lusaka
University of Zimbabwe Clinical Research Centre, Harare
University Hospital, Bordeaux
OTHER
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
PENTA Foundation
NETWORK
Centre Hospitalier Cocody
UNKNOWN
Malawi-Liverpool-Wellcome Trust Clinical Research Programme
OTHER
Eduardo Mondlane University
OTHER
Centro de Investigação em Saúde de Manhiça
OTHER
Stichting Katholieke Universiteit
OTHER
Barcelona Institute for Global Health
OTHER
University of Lincoln
OTHER
Makerere University
OTHER
University Teaching Hospital, Lusaka, Zambia
OTHER
University of Zimbabwe
OTHER
Kamuzu Central Hospital
OTHER
Servicio Madrileño de Salud, Madrid, Spain
OTHER
Hospital Universitario 12 de Octubre
OTHER